Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-02-02

FDA Approved: AMAZON BASIC CARE MIGRAINE RELIEF — Original Application (Amazon.com Services LLC)

View source ↗

Summary

FDA approved an original application for Amazon Basic Care Migraine Relief, a combination of acetaminophen, aspirin, and caffeine, as a generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMAZON BASIC CARE MIGRAINE RELIEF (Acetaminophen, aspirin and caffeine)

Snippet

ORIG AP for AMAZON BASIC CARE MIGRAINE RELIEF (ACETAMINOPHEN, ASPIRIN AND CAFFEINE)